Clinical Trials Logo

Clinical Trial Summary

Smell/taste disorders are common conditions with a significant impact on quality of life. In September 2021, a specific consultation for patients with smell and taste disorders was initiated at the ENT-HNS (ear, nose, and throat, head and neck surgery) department of UZ Leuven, partly in light of post-COVID-19 related smell disorders. With this observational ambidirectional study, we aim to better map smell/taste disorders in the Belgian/Flemish population. Using standard-of-care diagnostic tests and structured questionnaires, we strive to gain more insight into the severity, impact, and progression/prognosis of smell/taste disorders.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06456008
Study type Observational [Patient Registry]
Source Universitaire Ziekenhuizen KU Leuven
Contact Marnick Clijsters
Phone 003216348044
Email marnick.clijsters@gmail.com
Status Recruiting
Phase
Start date December 6, 2022
Completion date December 31, 2035

See also
  Status Clinical Trial Phase
Completed NCT04617444 - The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function N/A
Completed NCT02985515 - Steroid Nasal Irrigation for Flavor Evaluation and Detection Study N/A
Recruiting NCT06066307 - Olfactory Performance in Culinary Arts Students Phase 4
Completed NCT05445921 - Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction Phase 1/Phase 2
Recruiting NCT05855369 - Smell Training and Trigeminal Nerve Stimulation for COVID-related Smell Loss Phase 2/Phase 3
Recruiting NCT03574701 - Intranasal Retinoic Acid Treatment for Patients With OlfactoryLOSS: A RANDOMIZED CONTROLLED TRIAL N/A
Enrolling by invitation NCT04764981 - Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19) N/A
Completed NCT03990766 - Smell Changes & Efficacy of Nasal Theophylline Phase 2
Withdrawn NCT05542095 - Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia Phase 1
Recruiting NCT04791436 - Oral and Olfactory Complications of Recovered COVID-19 Patients
Enrolling by invitation NCT05038475 - Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19
Completed NCT01332825 - cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose N/A
Completed NCT04789499 - Smell in Covid-19 and Efficacy of Nasal Theophylline Phase 2
Active, not recruiting NCT04761458 - Correlation of Preoperative Global Olfactory Function With Frailty, Perioperative Neurocognitive Disorders and Mortality N/A
Completed NCT04406584 - Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction N/A
Completed NCT03611673 - At-Home Olfactory Training N/A
Completed NCT04700891 - Correlation of Preoperative Olfactory Identification Function With Frailty and Postoperative Complications and Mortality N/A
Recruiting NCT04466982 - Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection
Recruiting NCT04869436 - Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis Phase 4
Recruiting NCT05448898 - The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction N/A